An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Recruiting
Observational Study
Pulmonary Fibrosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 700 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The I-FILE study is a prospective multicenter, multinational observational study where the feasibility of a patient-led registry using home monitoring in patients with pulmonary fibrosis will be evaluated. The aim of the study is to gain more insights in disease behavior in patients with pulmonary fibrosis, so in future patients with progressive disease can be better identified.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Newly diagnosed patients with F-ILD according to the ATS/ERS criteria by a multidisciplinary ILD team :
* MDT diagnosis ≤ 6 months before inclusion
* Treatment for F-ILD ≤ than 1 month
Exclusion Criteria:
* Not able to speak, read or write in the native language of the countr…
Contacts